Raf-1 Activation Prevents Caspase 9 Processing Downstream of Apoptosome Formation
Author(s) -
Sébastien Cagnol,
Anna Mansour,
Ellen Van ObberghenSchilling,
JeanClaude Chambard
Publication year - 2010
Publication title -
journal of signal transduction
Language(s) - English
Resource type - Journals
eISSN - 2090-1739
pISSN - 2090-1747
DOI - 10.1155/2011/834948
Subject(s) - medicine , apoptosome , downstream (manufacturing) , microbiology and biotechnology , caspase , apoptosis , biochemistry , operations management , biology , programmed cell death , economics
In many cell types, growth factor removal induces the release of cytochrome-c from mitochondria that leads to activation of caspase-9 in the apoptosome complex. Here, we show that sustained stimulation of the Raf-1/MAPK1,3 pathway prevents caspase-9 activation induced by serum depletion in CCL39/ΔRaf-1:ER fibroblasts. The protective effect mediated by Raf-1 is sensitive to MEK inhibition that is sufficient to induce caspase-9 cleavage in exponentially growing cells. Raf-1 activation does not inhibit the release of cytochrome-c from mitochondria while preventing caspase-9 activation. Gel filtration chromatography analysis of apoptosome formation in cells shows that Raf-1/MAPK1,3 activation does not interfere with APAF-1 oligomerization and recruitment of caspase 9. Raf-1-mediated caspase-9 inhibition is sensitive to emetine, indicating that the protective mechanism requires protein synthesis. However, the Raf/MAPK1,3 pathway does not regulate XIAP. Taken together, these results indicate that the Raf-1/MAPK1,3 pathway controls an apoptosis regulator that prevents caspase-9 activation in the apoptosome complex.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom